Triumph Capital Management Bristol Myers Squibb CO Transaction History
Triumph Capital Management
- $270 Million
- Q4 2024
A detailed history of Triumph Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Triumph Capital Management holds 5,512 shares of BMY stock, worth $307,734. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,512
Previous 5,694
3.2%
Holding current value
$307,734
Previous $294,000
5.78%
% of portfolio
0.12%
Previous 0.11%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,751Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.36 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.31 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...